0 %

NEO-F-1200
Fully automated fluorometric workstation for newborn screening.

The NEO-F-1200 runs LaCAR's newborn screening assays from dried blood spot to result - pipetting, oscillating incubation, plate washing, fluorescence reading and data analysis in one integrated, walk-away system. Designed for professional use in clinical screening laboratories, it is also available as the lower-capacity NEO-F-500.

One integrated system handles every step of a fluorometric screening run. Load the dried blood spot plate and reagents, and the NEO-F-1200 takes over: elution, oscillating incubation, washing, fluorescence reading and result calculation - no manual transfer between steps. Its washing head aspirates the dried blood spot punches directly, and pressure-based detection (liquid level, clot, bubble) safeguards every pipetting action.

Scientific precision for minimal effort.

Key Features

icon fast
High speed and throughput
icon convenient
Fully automated.
No manual steps from plate to result.
icon flexibility
Multi-method batching
icon user-friendly
Intuitive and customizable software
icon practical
Efficient reagent and waste management
icon multiplexing
Supports up to 12 microplates simultaneously
icon adaptability
LIS and puncher connection available

Compatible assays

LaCar
Biotinidase deficiency
Fluo
The NEONATAL BTD Screening Fluo is an enzymatic assay designed to quantitatively measure biotinidase (BTD) activity levels in newborns, using dried blood spots, for the detection of biotinidase deficiency.
LaCar
Congenital Hypotyroidism TSH
Fluo
The NEONATAL TSH Screening FLISA is a fluorescent enzyme immunoassay designed for the quantitative measurement of thyroid stimulating hormone (TSH).
LaCar
Congenital Adrenal Hyperplasia 17-OHP
Fluo
The NEONATAL 17-OHP Screening FLISA is a fluorescent enzyme immunoassay designed for the quantitative measurement of 17 alpha-hydroxyprogesterone (17-OHP).
LaCar
Cystic Fibrosis IRT
Fluo
The NEONATAL IRT Screening FLISA is a fluorescent enzyme immunoassay for the quantitative determination of immunoreactive trypsinogen (IRT).
LaCar
Galactosemia GALT
Fluo
The NEONATAL GAL-T Screening Fluo is an enzymatic assay for the quantitative determination of galactose-1-phosphate uridyltransferase (GAL-T) activity levels.
LaCar
Galactosemia TGAL
Fluo
The NEONATAL T-GAL Screening Fluo is an enzymatic test for the fluorescence detection of D-galactose and galactose-1-phosphate in the context of neonatal screening for galactosemia.
LaCar
Maple Syrup Urine Disease
Fluo
The NEONATAL MSUD Screening Fluo is an enzymatic test which enables the fluorescence detection of 3 amino acids (leucine, isoleucine and valine) accumulated in case of maple syrup urine disease (MSUD) in newborns.
LaCar
Phenylketonuria
Fluo
The NEONATAL PKU Screening Fluo is an enzymatic test designed to screen newborns affected by phenylketonuria.

Research and Development

Our vision

At LaCAR, we envision a world where everyone benefits from rapid and reliable genetic diagnostics, enabling personalised healthcare while contributing to more equitable and sustainable global public health.

Aware of these challenges, our R&D team is committed to meeting the needs of customers and patients, taking into account the specific recommendations of different countries and continents, as well as advances in academic research and technology.

You have a question regarding our products ? You want to know more about our method ?

Contact